Epiphron Capital

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 1, 2021	LakeShore Biopharma	$130.0M Series B	OrbiMed, Dave Chenn	3W Capital, Adjuvant Capital, AIHC Capital, Eight Roads Ventures, F-Prime Capital, Haitong International, Hillhouse Capital, MSA Capital, Superstring Capital

Total Raised

N/A

Valuation

N/A